#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal achalasia Severe myoclonic epilepsy of infancy Hypoxic-ischaemic encephalopathy Desmoplastic small round cell tumour Endometrial cancer Oesophageal adenocarcinoma stage III Soft tissue necrosis Lymphatic malformation Pyruvate kinase deficiency anaemia Brain injury Tuberous sclerosis complex Ewing's sarcoma recurrent Erdheim-Chester disease Familial haemophagocytic lymphohistiocytosis Angelman's syndrome More trials…

    Learn about Rare Diseases

    Lymphangiosarcoma – Treatment Mantle cell lymphoma stage IV – Treatment Myelodysplastic syndrome with excess blasts – Life with Disease Nephroblastoma – Treatment Ewing’s sarcoma – Trials in Disease Rosai-Dorfman syndrome – Treatment Tuberous sclerosis complex – Basic Information Haemophilia Glycogen storage disease type I – Trials in Disease Hereditary motor and sensory neuropathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eprosartan Mesilate GRNA1599 Amiloride Ibutamoren Mesilate Asciminib Atomoxetine Methoxsalen Modafinil Ferric Carboxymaltose Clioquinol Azacitidine Sisunatovir Masofaniten Benzylpenicillin Abc-35B-116 Secale Cereale Tecovirimat Dinutuximab Beta Sar444656 Rusfertide More therapies…

    Learn about Your Condition

    Glomerulonephritis Small for dates baby Infertility Herpes virus infection Nervous system disorder Tonsillitis Mumps Pleural mesothelioma malignant Parkinson's disease Tachypnoea Tumour thrombosis Encephalitis Japanese B Bone sarcoma Non-Hodgkin's lymphoma Type 2 diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal transplant

  • Study on Reducing Tacrolimus Dose in Kidney Transplant Patients Using LCPT Compared to Tacrolimus-ER

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    • Renal transplant
    Investigated Drugs:
    • Tacrolimus
    The Netherlands

  • Study to Evaluate the Effectiveness of Pre-emptive Genotyping to Optimize Tacrolimus Dosage in Patients with Chronic Kidney Disease Awaiting Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Tacrolimus
    Spain

  • Study on the Effect of Eplerenone on Arterial Stiffness in Patients One Year After Kidney Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Eplerenone
    France

  • Study on the Effects of Calcium, Tacrolimus, and Mycophenolate Mofetil in Patients with Kidney Transplants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Calcium
    • Colecalciferol
    • Mycophenolate Mofetil
    Norway

  • Study of tacrolimus, everolimus and mycophenolate mofetil combination in elderly patients after kidney transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Basiliximab
    • Everolimus
    • Ciclosporin
    Belgium The Netherlands

  • Study of Tocilizumab Treatment for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    • Renal transplant
    Investigated Drugs:
    • Tocilizumab
    Spain Sweden
Previous Page
1 … 5 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!